Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors

Clinical trial NCT02077933 · COMPLETED

Trial details

NCT number: NCT02077933
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms Breast Neoplasms Kidney Neoplasms Pancreatic Neuroendocine Neoplasms (pNETs)

Start date: 2014-05-14
Primary completion: 2019-04-12
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.